1 study found for:    NOG
Show Display Options
Rank Status Study
1 Active, not recruiting Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Ozanezumab;   Drug: Placebo

Indicates status has not been verified in more than two years